Assessing the Longitudinal outcomes of Piperacillin/tazobactam versus ceftriAxone and metronidazole for Children with perforated Appendicitis (ALPACA): A protocol for a pilot randomized controlled trial
PLOS One · 2025
DOI: 10.1371/journal.pone.0335991 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift PLOS One, 2025. Verfasst von Daniel Briatico und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Appendicitis, Ceftriaxone, Metronidazole. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: McMaster University, Hamilton Health Sciences.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
Acute appendicitis is the most common indication for emergency surgery in children. In cases of perforation, patients require post-operative intravenous antibiotics in hospital. However, some children fail to respond adequately, resulting in prolonged hospitalization. The optimal antibiotic regimen for perforated appendicitis remains uncertain.
Methods
We propose a double-blind, randomized controlled pilot trial comparing two commonly used antibiotic strategies. Eligible participants include children
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Surgery, Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
- McMaster Pediatric Surgery Research Collaborative, McMaster University, Hamilton, Ontario, Canada.
- Division of Pediatric Infectious Disease, Department of Pediatrics, McMaster University, Hamilton, Ontario, Canada.
- Pediatric Emergency Medicine, McMaster Children's Hospital, Hamilton Health Sciences, Hamilton, Ontario, Canada.
- Department of Pediatrics, Cumming School of Medicine, University of Calgary, Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada.
- Paediatrics and Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.
ORCID-Profile: Daniel Briatico, Nadia Safa, Sarah Khan, Jeffrey Pernica
Förderung
- McMaster University
- Hamilton Health Sciences
Zitieren
APA
Briatico, D., Safa, N., Flageole, H., Khan, S., Pernica, J., Eltorki, M., Cohen, E., & Livingston, M. H. (2025). Assessing the Longitudinal outcomes of Piperacillin/tazobactam versus ceftriAxone and metronidazole for Children with perforated Appendicitis (ALPACA): A protocol for a pilot randomized controlled trial. PLOS One. https://doi.org/10.1371/journal.pone.0335991
Vancouver
Briatico D, Safa N, Flageole H, Khan S, Pernica J, Eltorki M, et al. Assessing the Longitudinal outcomes of Piperacillin/tazobactam versus ceftriAxone and metronidazole for Children with perforated Appendicitis (ALPACA): A protocol for a pilot randomized controlled trial. PLOS One. 2025. doi:10.1371/journal.pone.0335991
BibTeX
@article{Briatico2025,
author = {Briatico, Daniel and Safa, Nadia and Flageole, Helene and Khan, Sarah and Pernica, Jeffrey and Eltorki, Mohamed and Cohen, Eyal and Livingston, Michael H},
title = {Assessing the Longitudinal outcomes of Piperacillin/tazobactam versus ceftriAxone and metronidazole for Children with perforated Appendicitis (ALPACA): A protocol for a pilot randomized controlled trial},
journal = {PLOS One},
year = {2025},
doi = {10.1371/journal.pone.0335991}
}
EUVIMED